Penserra Capital Management LLC Roivant Sciences Ltd. Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$2.81 - $4.84 $590 - $1,016
210 Added 1.2%
17,771 $72,000
Q1 2022

May 13, 2022
SELL
$4.74 - $9.91 $144,517 - $302,145
-30,489 Reduced 63.45%
17,561 $86,000
Q4 2021

Feb 15, 2022
BUY
$5.86 - $13.52 $281,573 - $649,636
48,050 New
48,050 $484,000

Others Institutions Holding ROIV

# of Institutions
310
Shares Held
507M
Call Options Held
1.26M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.51B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email